Cargando…
Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) has been generally considered a genetic disease (disorder) with an aggressive tumor entity of highly proliferative malignant lymphoid cells. However, in recent years, significant advances have been made in the elucidation of the ALL-associated processes. Thus, we u...
Autores principales: | Zhang, Cheng, Zhong, Jiang F., Stucky, Andres, Chen, Xue-Lian, Press, Michael F., Zhang, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634719/ https://www.ncbi.nlm.nih.gov/pubmed/26543507 http://dx.doi.org/10.1186/s13148-015-0151-8 |
Ejemplares similares
-
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients
por: Advani, Anjali S, et al.
Publicado: (2010) -
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia
por: Parameswaran, Reshmi, et al.
Publicado: (2013) -
Human-derived normal mesenchymal stem/stromal cells in anticancer therapies
por: Zhang, Cheng, et al.
Publicado: (2017) -
Histone acetylation by HBO1 (KAT7) activates Wnt/β-catenin signaling to promote leukemogenesis in B-cell acute lymphoblastic leukemia
por: Wang, Hao, et al.
Publicado: (2023) -
Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)